CFTR and cystic fibrosis: All the experiments in their study were performed in primary human bronchial epithelial cells obtained from people with CF that were homozygous for the F508del CFTR mutation and, as such, treatment with VX-770 was only performed in conjunction with either VX-809 or VX-661, with both being correctors of the F508del CFTR mutation.